Search Results - "ALDIGIER, J.‐C."

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease by Locatelli, F, Mann, J F E, Aldigier, J C, Sanz Guajardo, D, Schmidt, R, Van Vlem, B, Sulowicz, W, Dougherty, F C, Beyer, U

“…C.E.R.A., a continuous erythropoietin receptor activator, is a long-acting erythropoiesis-stimulating agent (ESA) that is approved for the treatment of renal…”
Get more information

Molecular study of an IgG1κ cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia by GALEA, H. R., BRIDOUX, F., ALDIGIER, J.‐C., PARAF, F., BORDESSOULE, D., TOUCHARD, G., COGNÉ, M.

“…SUMMARY Glomerulonephritis with organized microtubular monoclonal immunoglobulin deposits (GOMMID) and glomerulonephritis related to type I cryoglobulin are…”
Get full text

Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl-N-Ser-Asp-Lys-Pro concentrations by COMTE, L., LORGEOT, V., VOLKOV, L., ALLEGRAUD, A., ALDIGIER, J.-C., PRALORAN, V.

“…Acetyl‐N‐Ser‐Asp‐Lys‐Pro (AcSDKP) is a physiological inhibitor of the proliferation of haematopoietic stem cells. In 12 healthy volunteers treated with the…”
Get full text

Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection by Le Meur, Yannick, Leprivey-Lorgeot, Valérie, Mons, Sandrine, José, Mattew, Dantal, Jacques, Lemauff, Brigitte, Aldigier, Jean-Claude, Leroux-Robert, Claude, Praloran, Vincent

“…Background. Macrophage-colony stimulating factor (M-CSF) is the principal factor for survival of monocytes and macrophages that play an important role in…”
Get full text

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites by ROUAN, M. C, LECAILLON, J. B, GODBILLON, J, MENARD, F, DARRAGON, T, MEYER, P, KOURILSKY, O, HILLION, D, ALDIGIER, J. C, JUNGERS, P

“…We have studied the effect of renal impairment on the pharmacokinetics of oxcarbazepine, its active monohydroxy-metabolite (which predominates in plasma),…”
Get full text

Analysis of three genetic markers in IgA nephropathy patients from a single region by Drouet, M, Aupetit, C, Denizot, Y, Bois, M, Bridoux, F, Aldigier, J C, Cogné, M

“…IgA nephropathy (IgA-N) is the most common glomerular disease. Various genetic factors have been suspected to influence the disease, but they never have been…”
Get more information

Whole blood production of monocytic cytokines (IL-1β, IL-6, TNF-α, sIL-6R, IL-1Ra) in haemodialysed patients by Le Meur, Yannick, Lorgeot, Valérie, Aldigier, Jean-Claude, Wijdenes, John, Leroux-Robert, Claude, Praloran, Vincent

“…Background. The production of monocytic cytokines by isolated mononuclear cells after stimulation by phytohaemagglutinin (PHA) and lipopolysaccharide (LPS) is…”
Get full text

Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans by Aldigier, J C, Huang, H, Dalmay, F, Lartigue, M, Baussant, T, Chassain, A P, Leroux-Robert, C, Galen, F X

“…Physical effort stimulates the reninangiotensin system (RAS). We studied the effect of an angiotensin-converting enzyme inhibitor (ACE inhibitor) in a…”
Get more information

Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome by Poux, J M, Boudet, R, Lacroix, P, Jauberteau, M O, Plouin, P F, Aldigier, J C, Leroux-Robert, C

“…Renal manifestations of the "primary" antiphospholipid syndrome are rare. We report the case of an athletic 35-year-old man with an unremarkable medical…”
Get more information

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen by Chambaraud, T., Dickson, Z., Ensergueix, G., Barraud, O., Essig, M., Lacour, C., Allard, J., Bocquentin, F., Aldigier, J.C., Rerolle, J.P.

“…Bordetella holmesii is a gram‐negative rod that was initially identified in 1995. It causes bacteremia, pneumonia, and endocarditis mostly in patients with…”
Get full text

Deregulated platelet‐activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy by Denizot, Yves, Aupetit, Corinne, Bridoux, Franck, Alphonse, Jean‐Claude, Cogné, Michel, Aldigier, Jean Claude

“…Background. Platelet‐activating factor (PAF) is a phospholipid mediator with potent inflammatory activities. PAF stimulates IgA synthesis by B cells while IgA…”
Get full text

Macrophage colony stimulating factor involvement in uremic patients by Meur, Yannick Le, Fixe, Philippe, Aldigier, Jean-Claude, Leroux-Robert, Claude, Praloran, Vincent

“…Macrophage colony stimulating factor involvement in uremic patients. The immunodeficiency of patients with chronic renal failure (CRF) is related to multiple…”
Get full text

Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate by Le Meur, Y, Moesch, C, Rincé, M, Aldigier, J C, Leroux-Robert, C

“…We report two cases of acute renal failure in patients with arteriosclerosis obliterans treated by intravenous infusion of naftidrofuryl oxalate. At renal…”
Get more information

Safety of the combination of valsartan and benazepril in patients with chronic renal disease by RUILOPE, L. M, ALDIGIER, J. C, PONTICELLI, C, ODDOU-STOCK, P, BOTTERI, F, MANN, J. F

Get full text

Acute renal failure in a marathon runner: role of glomerular bleeding in tubular injury by Le Meur, Y, Paraf, F, Szelag, J C, Aldigier, J C, Leroux-Robert, C

Get more information

Is Plasma Ac-SDKP Level a Reliable Marker of Chronic Angiotensin-Converting Enzyme Inhibition in Hypertensive Patients? by Le Meur, Yannick, Aldigier, Jean-Claude, Praloran, Vincent

Get full text

Regulation of erythropoiesis by bone marrow reninangiotensin system: facts and speculations by Praloran, V, Comte, L, Le Meur, Y, Aldigier, J C

Get more information

Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril by BEVAN, E. G, MCINNES, G. T, ALDIGIER, J. C, CONTE, J. J, GRUNFELD, J. P, HARPER, S. J, MEYER, B. H, PAULY, N, WILKINSON, R

“…1. The pharmacokinetics and pharmacodynamics of a single dose of trandolapril, an angiotensin converting enzyme (ACE) inhibitor with an active metabolite,…”
Get full text

Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements by Le Meur, Yannick, Lorgeot, Valérie, Comte, Lydie, Szelag, Jean-Christophe, Aldigier, Jean-Claude, Leroux-Robert, Claude, Praloran, Vincent

“…N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a physiological inhibitor of hematopoiesis that is maintained at stable levels in normal plasma. Its…”
Get full text

Protection of Renal Function with ACE Inhibitors: Experience with Benazepril by Aldigier, J C, Meur, Y L, Brunel, P

“…Research into progressive renal scarring has been closely linked over the last two decades with angiotensin II (AII). This has led to a better understanding of…”
Get full text